MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2

Yonglian Huang(China Medical University), Zhen Liu(Qinghai University), Chenxi Liu(China Medical University), Mingyue Guo(University of Electronic Science and Technology of China), Lidong Wang(University of California San Diego), Hao Tan(China Medical University), Hengwei Zhang(Ningbo University)
Cancer Cell International
September 16, 2021
Cited by 14


Related Papers